You have 9 free searches left this month | for more free features.

City

Changsha (1)

Shanghai (1)

Condition

Metastatic Castration Resistant Prostate Cancer (2)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

Hinova Pharmaceuticals Inc. (2)

Collaborator

Intervention

hc1119 (2)

enzalutamide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

hc1119

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Castration Resistant Prostate Cancer Trial in Shanghai (HC1119)

Completed

Metastatic Castration Resistant Prostate Cancer

HC1119

Shanghai, China

Shanghai Changhai Hospital Ethics Committee

Oct 30, 2020

Metastatic Castration Resistant Prostate Cancer Trial in Changsha (Enzalutamide, HC1119)

Completed

Metastatic Castration Resistant Prostate Cancer

Enzalutamide
HC1119

Changsha, China

Medical Ethics Committee of Hunan Cancer Hospital

Oct 30, 2020